Fulcrum Equity Management’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,729
Closed -$353K 101
2022
Q1
$353K Sell
2,729
-3,275
-55% -$472K 0.21% 71
2021
Q4
$1.08M Sell
6,004
-337
-5% -$58.5K 0.41% 62
2021
Q3
$941K Buy
+6,341
New +$971K 0.37% 66

Other funds holding OMCL

Fulcrum Equity Management's OMCL Position: Q2 2022 in Review

Fulcrum Equity Management sold out of Omnicell (OMCL) in Q2 2022, closing a stake of 2,729 shares — an estimated $353K sold.

Fulcrum Equity Management first reported a position in OMCL in Q3 2021 and held it in 3 quarters. The position peaked at $1.08M in Q4 2021. 385 funds tracked by Wall St. Rank hold OMCL as of Q2 2022.

  • Fulcrum Equity Management reported no remaining Omnicell position as of Q2 2022 after selling out during the quarter.
  • Fulcrum Equity Management sold 2,729 Omnicell shares in Q2 2022, an estimated $353K.
  • Fulcrum Equity Management first reported a position in Omnicell in Q3 2021 and held it in 3 quarters.
  • Fulcrum Equity Management's Omnicell position peaked at $1.08M in Q4 2021.
  • 385 funds tracked by Wall St. Rank held Omnicell as of Q2 2022.

Based on Fulcrum Equity Management's 13F filing for Q2 2022, filed 18 Jul 2022.